Company · CIK 0001690585 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Dianthus Therapeutics, Inc. /DE/ · DNTH
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 SForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $101.38 | $2,027,646 | 0 | −100% | 10b5-1 |
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | $17.88 | $357,600 | 20,000 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $106.41 | $2,460,690 | 4,000 | −85.3% | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | $20.63 | $477,047 | 27,124 | — | 10b5-1 |
| Aug 19, 2026 SForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | $117.55 | $326,554 | 0 | −100% | 10b5-1 |
| Aug 19, 2026 MForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | $18.36 | $51,004 | 2,778 | — | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 15,000 | $18.17 | $272,550 | 15,000 | — | |
| Aug 10, 2026 SForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | $109.01 | $844,822 | 0 | −100% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | $12.52 | $97,000 | 7,750 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | $109.55 | $304,232 | 0 | −100% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | $18.36 | $50,986 | 2,777 | — | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | $110.44 | $2,208,833 | 0 | −100% | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | $17.88 | $357,600 | 16,167 | — | 10b5-1 |
| Aug 7, 2026 SForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | $108.11 | $17,945,451 | 65,292 | −71.8% | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | $8.44 | $1,401,040 | 231,292 | — | 10b5-1 |
| Jul 9, 2026 SForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | $101.03 | $3,157,151 | 0 | −100% | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | $21.77 | $680,291 | 31,249 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | $80.80 | $2,423,958 | 0 | −100% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | $17.88 | $536,400 | 30,000 | — | 10b5-1 |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:36 pm EDT | Atlas Venture Fund X, L.P. +210% Owner | 4,746,876 | — | — | 4,843,625 | — | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 4:36 pm EDT | David ScaddenDirector | 6,600 | $15.00 | $99,000 | 228,175 | +2.98% | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:36 pm EDT | David ScaddenDirector | 28,076 | — | — | 221,575 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:34 pm EDT | Third Rock Ventures IV, L.P. +210% Owner | 7,911,455 | — | — | 8,008,204 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:34 pm EDT | Thomas O DanielDirector | 24,527 | — | — | 101,926 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:31 pm EDT | Amy L RonnebergDirector | 593,611 | — | — | 593,611 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Michael P. CookeChief Scientific Officer | 4,370 | — | — | 293,023 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Zoran ZdraveskiSee Remarks | 4,643 | — | — | 140,092 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Christina K. IsacsonChief Business Officer | 2,912 | — | — | 103,531 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:28 pm EDT | GV 2016 GP, L.L.C. +310% Owner | 3,339,137 | — | — | 3,339,137 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:28 pm EDT | Bruce BoothDirector | 4,746,876 | — | — | 4,843,625 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:27 pm EDT | Michael W BonneyDirector | 21,847 | — | — | 215,346 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:27 pm EDT | Jeffrey W. AlbersDirector | 4,152 | — | — | 4,152 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:25 pm EDT | Blake ByersDirector | 3,339,137 | — | — | 3,339,137 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | John C. Davis Jr.Chief Medical Officer | 8,304 | — | — | 8,304 | — | plan? |
| Jun 25, 2018 PForm 4 → | Jun 27, 4:24 pm EDT | Jason GardnerSee Remarks, Director | 400 | $15.00 | $6,000 | 363,212 | +0.11% | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | Jason GardnerSee Remarks, Director | 47,396 | — | — | 359,092 | — | plan? |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | Alexis BorisyDirector | — | — | — | 0 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 MForm 4 → | Sep 18, 4:36 pm EDT | Edward CarrCHIEF ACCOUNTING OFFICER | 20,000 | — | — | 43,818 | — | 10b5-1 |
| Sep 1, 2026 MForm 4 → | Sep 3, 4:30 pm EDT | Simrat RandhawaEVP, Head of R&D | 23,124 | — | — | 87,500 | — | 10b5-1 |
| Aug 19, 2026 MForm 4 → | Aug 19, 6:02 pm EDT | Simon ReadDirector | 2,778 | — | — | 19,445 | — | 10b5-1 |
| Aug 13, 2026 MForm 4 → | Aug 14, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 15,000 | — | — | 73,240 | — | |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:15 pm EDT | Anne McGeorgeDirector | 7,750 | — | — | 0 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 11, 5:10 pm EDT | Simon ReadDirector | 2,777 | — | — | 22,223 | — | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 11, 5:08 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 20,000 | — | — | 60,000 | — | 10b5-1 |
| Aug 7, 2026 MForm 4 → | Aug 7, 6:30 pm EDT | Marino GarciaCEO AND PRESIDENT, Director | 166,000 | — | — | 160,004 | — | 10b5-1 |
| Jul 9, 2026 MForm 4 → | Jul 13, 5:00 pm EDT | Ryan SavitzEVP, CFO & CBO | 31,249 | — | — | 68,751 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 18, 4:30 pm EDT | Adam M VenessSVP, General Counsel and Sec. | 30,000 | — | — | 80,000 | — | 10b5-1 |
| Feb 5, 2019 AForm 4 → | Feb 7, 4:23 pm EST | Zoran ZdraveskiSee Remarks | 80,000 | — | — | 80,000 | — | |
| Feb 5, 2019 AForm 4 → | Feb 7, 4:20 pm EST | John C. Davis Jr.Chief Medical Officer | 70,000 | — | — | 70,000 | — | |
| Feb 5, 2019 AForm 4 → | Feb 7, 4:19 pm EST | Michael P. CookeChief Scientific Officer | 64,000 | — | — | 64,000 | — | |
| Feb 5, 2019 AForm 4 → | Feb 7, 4:18 pm EST | Jason GardnerSee Remarks, Director | 182,900 | — | — | 182,900 | — | |
| Feb 5, 2019 AForm 4 → | Feb 7, 4:16 pm EST | Christina K. IsacsonChief Business Officer | 80,000 | — | — | 80,000 | — | |
| Jan 2, 2019 AForm 4 → | Jan 4, 4:16 pm EST | Jason RyanSee Remarks | 329,379 | — | — | 329,379 | — | |
| Sep 25, 2018 AForm 4 → | Sep 27, 4:15 pm EDT | Amy L RonnebergDirector | 52,244 | — | — | 52,244 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:36 pm EDT | Atlas Venture Fund X, L.P. +210% Owner | 12,265,835 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:36 pm EDT | David ScaddenDirector | 72,548 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:34 pm EDT | Third Rock Ventures IV, L.P. +210% Owner | 20,443,044 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:34 pm EDT | Thomas O DanielDirector | 63,378 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:31 pm EDT | Amy L RonnebergDirector | 1,533,881 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Michael P. CookeChief Scientific Officer | 11,292 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Zoran ZdraveskiSee Remarks | 12,000 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:30 pm EDT | Christina K. IsacsonChief Business Officer | 7,527 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:28 pm EDT | GV 2016 GP, L.L.C. +310% Owner | 8,628,264 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:28 pm EDT | Bruce BoothDirector | 12,265,835 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:27 pm EDT | Michael W BonneyDirector | 56,454 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:27 pm EDT | Jeffrey W. AlbersDirector | 10,729 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:25 pm EDT | Blake ByersDirector | 8,628,264 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | John C. Davis Jr.Chief Medical Officer | 21,459 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | Jason GardnerSee Remarks, Director | 122,473 | — | — | 0 | — | |
| Jun 25, 2018 CForm 4 → | Jun 27, 4:24 pm EDT | Alexis BorisyDirector | — | — | — | 0 | — |